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Introduction
This is not a meeting report. Any attempt to summarize a
4-day meeting with a multitude of parallel sessions,
posters and other activities is doomed to be either biased
or superficial, or both. Rather, the aim is to give a personal
account of some reflections in the mind of an old Euro-
pean after attending what turned out to be the largest con-
gress in the history of our specialty. It should be known
that I made no secret of my disappointment with some
arrangements in last year’s 1st Annual EULAR Congress
in Nice. The editors’ invitation to write about Prague gives
me the opportunity to air some views and hopes.
Biggest in the world
The 8300 registered delegates made this the largest
EULAR, and probably rheumatology, congress ever. The
turnout does not become less impressive considering that
registration was not cheap: 800 Euro on site. The income
for the EULAR should make the outgoing treasurer, Josef
Smolen (Vienna), and the incoming Ferdinand Breedveld
(Leiden) happy. Even the 10% of the surplus that goes to
the hosting Czech society will be good news to Karel
Pavelka, the president of the meeting, and his countrymen.
In addition to all the money from registration fees, the
organization received revenue from no less than 17 satel-
lite industrial symposia, industrial exhibitors, and so on.
This commercial success makes the EULAR economically
sound, which is certainly not a negative thing. The concern
is, however, related to the fact that at least 80% of the del-
egates were sponsored by industry. Some companies
were flying in over 1000 delegates from all continents. The
individual who pays his own way is an endangered
species at the EULAR congresses. Availability of grant
money to attend congresses is limited, and in some
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The 2nd Annual European League Against Rheumatism (EULAR) Congress, held in Prague, 13–16
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of first-class state of the art lectures by some 180 invited worldwide speakers. Several new and
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of rheumatology, the other being the American College of Rheumatology meeting.
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countries is extremely limited. The generous travel spon-
sorship of industry eliminates motivation for the organizers
to reduce registration fees. It should be added, however,
that the fee includes an annual subscription to Annals of
the Rheumatic Diseases, the EULAR journal, thereby
increasing the circulation of this journal.
Who was in attendance and who was not
It was delightful to meet so many faces of friends at the
opening reception, blessed by perfect weather and held in
the generous foyer of the Prague Congress Centre. The
faces were those of the invited speakers, of colleagues
flown in by industry from European and non-European
countries, and those of industry. The decision-makers and
the speakers in the satellites were numerous, as were the
regular practicing rheumatologists from both east and
west. The stage was set for a mega postgraduate
meeting. You had to look harder for investigators, both
younger and older, and many of these (who are regulars at
the American College of Rheumatology [ACR] meetings)
did not find it attractive or affordable to come to Prague.
When the EULAR decided to move to annual congresses,
one aim was to capture this core group of active basic and
clinical investigators. Some of these indeed made it to
Nice, but were utterly disappointed and abstained from
Prague. It will be a hard challenge for the EULAR to attract
them back. One indicator of failure in this sense was the
low number of abstracts submitted to Prague, approxi-
mately 1200, in contrast to 3600 for this year’s ACR
meeting in San Francisco. And it can be no secret that the
quality of the 750 accepted posters was mixed.
The opening ceremony
At the opening ceremony in the splendid congress
center, the main congress hall with its 2300 seats was
nearly full. It was a relaxed event lead by a professional
Master of Ceremonies; the speeches were kept to a
minimum and included one by the Minister of Health, a
university professor. A film showed the history of the city
and the country from medieval times to the present, only
omitting the Nazi and Communist interludes. Prizes were
awarded to a number of young investigators, to one
senior team and to the nestor of European rheumatology,
Eric GL Bywaters, who at the age of 91 is in good mental
and physical health. Meeting Professor Bywaters, who
has fostered so many generations of rheumatologists and
set the standards for excellence in clinical research, was
one of the highlights of this congress. As a young pathol-
ogist performing cartilage research in the Courtauld insti-
tute, he was visited by Walter Bauer from the
Massachusetts General Hospital in Boston. Following an
invitation from Dr Bauer, he spent 2 years in Boston and
built an early bridge between Europe and the United
States. Serving in London’s Hammersmith hospital during
the Blitz, he described the ‘crush syndrome’ with its then
fatal renal tubular necrosis. Among his classical contribu-
tions are the necrotic vasculitis lesions of the fingers,
called Bywaters’ lesions.
The scientific podium presentations
The invited speakers numbered 180 and included a good
mix of leaders in clinical and basic research. There were
between three and eight concurrent review sessions or
themed sessions to choose from throughout. One could
enjoy first-class state of the art information spiced with
some new information. There were also podium presenta-
tions of some good selected abstracts. One session
deserves special mention; the ‘Scientific forum for young
rheumatologists’, which included speakers who had par-
ticipated in the ACR/EULAR exchange program. I unfortu-
nately could not attend this session because I was
speaking in a concurrent session. Several sessions were
composed exclusively of invited speakers, and these were
of the highest quality. In some sessions, the ambition was
to mix invited presentations with selected abstract presen-
tations. These sessions often started with a full house;
however, much of the audience left when the selected
abstract presenters took the floor. The organizers are well
aware of this problem, and are looking for ways to over-
come it. I could not help thinking of other recent meetings,
like the British Society for Rheumatology Annual General
Meeting in Edinburgh, where delegates in general sat
through until the end of the sessions. Such problems are
of particular importance if one seeks to attract presenters
of original, not yet published work. I also noted that after-
noon sessions in general had a thinner attendance, and I
know that some drug companies had arranged social
activities starting while the scientific program was still in
progress. This behavior should be formally barred through
agreement between the EULAR and industry.
The logistics of poster sessions
The poster sessions were a great improvement compared
with the first annual congress in Nice. The time allotted
every morning did not overlap with any official sessions,
only with committee meetings and similar activities. Yet
the attendance was thin and, even worse, many posters
were unmanned or even not mounted. And, as already
mentioned, the quality was mixed. The panels were too
narrow and close together, which made it hard to view
some of the popular posters. There are plans to move the
poster sessions to the lunch break at the next EULAR con-
gress in Stockholm, 2002. This would then be combined
with provision of light food and drink, and hopefully
improve attendance. I am attracted by this idea, provided
industry and conveners of committee meetings abstain
from clashing with the poster hours.
The satellite symposia
The drug industry has delivered a number of powerful new
remedies in recent years and more are in the pipeline. This
is a good thing, and it has helped rheumatologists to help3
patients. The enormous expansion of the EULAR Con-
gress and other congresses are made possible by industry
support. It was said that 80% of the delegates’ registra-
tion was carried by industry, in addition to direct fees paid
to the congress organizers. It is understandable that
industry expects a return for such services. The satellites
in their present form are sales events dressed up into sci-
entific sessions. The speakers are paid by industry for their
services and their selection must be sanctioned by the
sponsor. Having said this, I must also add that, in general,
the speakers are highly reputable investigators who
present original work. Much of the presented material
meets high standards of postgraduate teaching. Neverthe-
less, one must keep in mind that the hosting event is ulti-
mately intended to boost the sale of products. In my view,
satellites should be held before and/or after scientific con-
gresses, and not while they are in progress. There is a limit
to what most brains can digest in one day and attending
satellites by necessity competes for brain input capacity.
Furthermore, delegates whose congress presence is
sponsored by an industry feel a natural guilt if they do not
attend their sponsor’s satellite. And, after all, we not only
attend congresses to listen to talks or discussions; we
also want to meet old and new friends and colleagues.
This latter need is of course met in splendid ways by
numerous social events sponsored by industry. The purist
may experience ethical difficulties attending such events,
and industry could argue that the satellites provide as
good science as the congress itself and that one will not
happen without the other. This obviously is a tricky issue.
The pre-congress organization
Abstract submission was exclusively electronic this time. I
know several people, including myself, who had difficulties
delivering their abstract. I found to my surprise that the
abstract book said ‘No abstract received’ in my and several
other slots. The EULAR needs to improve on this detail,
which works so well at the ACR meetings. Another wish is
that the program abstract book becomes available in time
before the meeting so that one can make choices among
the up to 10 concurrent sessions. Being an invited
speaker, I had no problem with hotel reservation, but I
know that individuals not invited by the congress or by
industry were less fortunate if they were not making reser-
vations extremely early. Again, the ACR has arrived at a fair
way to handle this problem by fixing a date before which no
reservations are accepted, and requiring registration to the
congress before allowing housing reservations.
The future of European rheumatology
meetings
In recent years, some EULAR officials expressed the view
that the new annual congress should substitute for the
national or regional meetings held in most if not in all Euro-
pean countries. This has clearly not happened and is not
likely to happen in the near future. Recent British, French
and German congresses have had undiminished and
good attendance. Although one commonly complains
about too many meetings, one rarely stays home. Con-
gress life is attractive to most health workers, not only
doctors and not only rheumatologists. There is no ques-
tion that the national as well as the EULAR congresses
offer first-class state of the art information and help in
postgraduate teaching. But do they fulfil the need for sci-
entific exchange? The European Workshop for Rheumato-
logic Research, an annual event, started more than two
decades ago by Professor Gabriel Panayi of London, is a
good example of what one can do with a limited budget
and focused organization. The rule for this meeting is to
admit only delegates coauthoring an abstract and to not
accept more than 150 abstracts. Should one try to let the
European Workshop for Rheumatologic Research expand
into a European Rheumatology Research Society, perhaps
meeting shoulder to shoulder with the EULAR? This form
is, for example, adopted by American orthopedics. Time
seems not ready for such a change, so the effort for the
EULAR must be to become a more attractive platform to
present the best science. This will not happen overnight. I
know that the EULAR leadership is well aware of the
problem and will continue to encourage the young
researcher’s participation. The EULAR is now in a position
to use some of its wealth for the purpose. This would be
more appealing than steering towards a split. I hope the
efforts will be successful.
Concluding remarks
The largest ever (?) rheumatology congress in Prague was
a sounding success in several ways. The scientific com-
mittee had organized excellent scientific state of the art
sessions in a large number of areas, appeasing most inter-
ests and tastes. The local organization was very good and
the venue excellent. The EULAR Annual Congress
emerges as one of the two most influential congresses in
the field of rheumatology. It should be possible to attract
more abstracts to future meetings and make the poster
sessions livelier.
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